Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a… Amit Mookim Jan 24, 2025 Amit Mookim, CEO, Immuneel Therapeutics urges the govt to focus on establishing a strong compliance framework and expediting…
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData EP News Bureau Mar 13, 2021 Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
Pfizer and CStone to collaborate for oncology therapies in China EP News Bureau Sep 30, 2020 CStone to receive up to $280 million in milestone payments for sugemalimab, and additional royalties
Cancer CART therapy: What are the benefits and stakes? EP News Bureau Jun 13, 2020 Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…